A microRNA survival signature (MiSS) for advanced ovarian cancer.
Gynecol Oncol
; 121(3): 444-50, 2011 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-21354599
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
MicroRNAs
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Gynecol Oncol
Year:
2011
Type:
Article
Affiliation country:
United States